Beam Therapeutics · 6 days ago
VP, Head of Key Account Managers
United States
Full-time
Remote
Director/Executive
$310K/yr - $400K/yr
15+ years expBeam Therapeutics is seeking a dynamic Head of Key Account Management to lead the national treatment center engagement and launch of risto-cel, a potential best in class gene therapy for sickle cell disease. This high-impact commercial leadership role involves hiring and overseeing a team of account leaders to ensure operational excellence and patient delivery at treatment centers.
BiotechnologyGeneticsMedicalTherapeutics
Hiring Manager
Sarah Oleson
Responsibilities
Hire, lead, develop, and inspire the national team of Key Account Managers responsible for relationships with authorized treatment centers ensuring seamless patient access while building deep institutional connections with administrators, clinicians, and operational stakeholders
Drive excellence in site onboarding, ensuring business readiness and optimize gene therapy delivery infrastructure
Build strategic partnerships with treatment centers and referral sites to optimize patient identification, referral pathways, and treatment initiation
Serve as the commercial “face” of the treatment network—representing the company with providers, administrators, and other key stakeholders
Collaborate cross-functionally with Field Reimbursement, Medical Affairs, Patient Operations, and Patient Services to deliver a unified site experience
Monitor site performance metrics, identify barriers, and implement solutions that enhance site efficiency and patient access
Qualification
Required
Bachelor's degree required
15+ years of commercial experience in biotech or specialty pharmaceuticals, including 3+ years in cell or gene therapy (CAR T or equivalent)
Proven leadership and people management experience—able to motivate and develop a high-performing, field-based team
Deep understanding of treatment center operations, referral dynamics, and patient access challenges in rare or complex therapies
Strong cross-functional collaboration skills and comfort working in a fast-moving, launch-focused environment
Preferred
advanced degree (MBA, MS, PharmD, or equivalent)
Company
Beam Therapeutics
Beam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology.
501-1000 employees
Funding
Current Stage
Public CompanyTotal Funding
$1.19B2025-03-10Post Ipo Equity· $500M
2021-01-19Post Ipo Equity· $260M
2020-02-11Post Ipo Equity· $207M
Leadership Team
John Evans
CEO
Christine Bellon
Chief Legal Officer
Recent News
2026-01-23
2026-01-13
Company data provided by crunchbase